Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial...
Home »
NDTV News - India-news
» LIVE: Covaxin Phase 3 Trials Efficacy At 81 Per Cent, Says Bharat Biotech
No comments:
Post a Comment